Tag: genomics
-
Gene Therapy Start-Up Gains $38M in Early Funds
A new company developing genetic treatments with a high-capacity engineered virus to deliver its therapeutic payloads is raising $38 million in venture funds.
-
Life Science Investors Raise $1.1B for New Fund
A venture capital company specializing in health and life sciences start-up enterprises is raising $1.1 billion for a new investment fund.
-
Sites Revealed for Lung Cancer Precision Diagnostic Trial
The first sites are selected for a study testing people with suspected lung tumors for cancer-causing mutations, to help decide on personalized treatments for their disease.
-
Challenge Seeks Tech, Models to Reduce Stillbirths
A research competition is seeking better technologies to measure gestational development and predict outcomes to reduce the number of stillbirths by half.
-
Biobank Study to Assess Obesity Types, Genetics
A study is now enrolling individuals to better understand different types of obesity, as well as genetics and other factors behind various obesity conditions.
-
High Speed Genetics Tech Start-Up Raises $15M
A start-up enterprise developing a high-performance genomic screening and detection technology is raising $15 million in early financing.
-
Venture Investor Funds Cell Therapy Targeting Tech
A venture capital company is funding biomedical engineering research to improve the reach and targeting of cell therapies to more diseases.
-
Precision Antibacterial Company Raises $35M in New Funds
A biotechnology company creating targeted antibacterial and microbiome treatments aided by gene editing is raising $35 million in new venture funds.
-
Trial Shows Gene Therapy Results with Sickle Cell Disease
Early results from a clinical trial show an experimental gene transfer therapy largely reduces painful events from sickle cell disease for one to two years.
-
Early Trial Data Show Crispr Cancer Therapy Response
Initial results from a clinical trial show non-Hodgkin lymphoma patients receiving low doses of gene-edited T-cells achieve a clinical response, but with some adverse effects.